Japan’s healthcare system to include new obesity treatment in insurance coverage
Japan’s healthcare system is set to introduce a novel obesity treatment covered by public medical insurance starting Wednesday (22nd of November, 2023), marking the first such inclusion in thirty years. Wegovy, produced by the Danish firm Novo Nordisk, will be accessible under the national health insurance following its approval for manufacture and sale in March. The treatment...Read MoreNovo Nordisk’s $2.3 billion French investment to enhance obesity drug output
Novo Nordisk has declared a substantial $2.3 billion investment aimed at amplifying the output of its highly sought-after obesity and diabetes medications at its Chartres facility in France, in a move to satiate the escalating demand. This financial injection will notably enhance the manufacturing capabilities for existing products such as Ozempic and Wegovy, alongside other burgeoning...Read MoreAstraZeneca launches Evinova, aiming to revolutionise clinical trials with digital solutions
AstraZeneca has initiated a foray into the burgeoning field of health technology with the introduction of its new subsidiary, Evinova. Officially unveiled this past Monday (20th of November, 2023), Evinova is poised to redefine how clinical trials are conducted for biotechnology entities, pharmaceutical corporations, and Contract Research Organisations (CROs). By integrating digital health...Read MoreOECD highlights digital health as key to enhancing healthcare system performance
The latest Organisation for Economic Co-operation and Development (OECD) report throws light on the financial strains faced by health systems in member countries, driven by the allocation competition for public funds. The report, ‘OECD Health at a Glance 2023‘, unveils that healthcare expenditure in OECD nations represented 9.2% of GDP in 2022, a slight reduction from 9.7% in the...Read MoreCCH expands educational horizons in Indonesia with key partnership
JAKARTA, Indonesia – In a significant move to expand educational opportunities in Indonesia, the College of Contemporary Health’s (CCH) Dzidek Sabat has successfully forged a new path of collaboration with one of Indonesia’s most prestigious educational institutions. During his recent visit, Dzidek met with officials from the Makara UI Academy, a division of the esteemed University of...Read Moreby Nicholas FeenieNovember 21, 2023 Medication, Obesity and Population Health, Obesity in Europe0 comments